혈류 감염 검사 시장 : 제품 유형별, 검체 유형별, 기술별, 최종사용자별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Bloodstream Infection Testing market size was valued at US$ 830.4 Million in 2025, expanding at a CAGR of 4.4% from 2026 to 2033.

The Bloodstream Infection Testing market will experience significant growth due to increasing disease prevalence, rising incidence of hospital-acquired infections, and increasing demand for rapid diagnostic solutions. Bloodstream infection testing devices are used in hospitals, diagnostic centers, and ICUs in order to detect pathogens in their early stages and aid in the process of antimicrobial therapy. There is a growing use of PCR-based tests, a rise in the number of automated blood culture systems, and the increased use of molecular diagnostics. Fast diagnostic methods, particularly in reducing deaths from severe Bloodstream infection, are extremely important to the healthcare sector. Growth in microbiology automation, parallel testing, and pathogen diagnosis drives the growth of the Bloodstream Infection Testing market and makes it an essential part of critical care management. These advancements reinforce Bloodstream infection testing as a critical pillar of modern critical care.

Bloodstream Infection Testing Market- Market Dynamics

Increasing Prevalence Of Sepsis And Healthcare-Associated Infections to Drive Market Expansion

Increasing prevalence of sepsis and healthcare-associated infections is expected to drive demand for Bloodstream infection testing because Bloodstream infection tests would be helpful for the identification of the pathogens causing the infections and effective treatment. For example, in September 2025, the Australian Commission on Safety and Quality in Health Care (Gov) states that there are more than 84,000 sepsis cases in public hospitals in Australia in September 2025, when the Sepsis Epidemiology Report suggests that there are more than 900,000 cases of sepsis admissions, which means that there is an increasing burden of sepsis. The increasing burden of sepsis is also reflected by the fact that about one-third of those who are hospitalized for sepsis suffer from diabetes and one-sixth suffer from kidney disorders. Additionally, sepsis admission rates are twice as high for the indigenous population (Aboriginal and Torres Strait Islanders) as compared to the non-indigenous population. These findings highlight the urgent need for rapid diagnostic tools to mitigate sepsis burden.

Bloodstream Infection Testing Market- Segmentation Analysis:

The Global Bloodstream Infection Testing market is segmented on the basis of Product, Sample Type, Technology, End User, and Region.

In terms of sample type, blood culture represents the most significant segment in the Bloodstream Infection Testing market because of an increasing requirement for the timely detection of pathogens in the Bloodstream of a patient. In June 2026, Bruker Corporation said that there was tremendous growth of Bruker within the domain of microbiology and infectious disease diagnostics, including Bruker's Arc(TM) automated sample preparation system for positive blood cultures and rapid antimicrobial susceptibility testing workflow for Bloodstream infections and sepsis. These innovations highlight blood culture's pivotal role in advancing rapid diagnostics for critical Bloodstream infections.

Bloodstream Infection Testing Market- Geographical Insights

North America holds a considerable place in the Bloodstream Infection Testing market due to a number of reasons, including advanced technologies, adoption of molecular diagnostic methods in healthcare facilities, strict infection control practices, and favorable reimbursement policies. For instance, in July 2026, according to the Centers for Disease Control and Prevention (Gov), there was a decrease in Bloodstream infections caused by central lines by 9%, as seen in the United States in acute care hospitals and central line Bloodstream infections (CLABSIs), where there was a decline of 10% in ICU units and 9% in ward units. Furthermore, the report reveals that in the US, 46 states have performed better than the 2015 national baseline to prevent CLABSI in acute care hospitals, which indicates a continuous growth rate of Bloodstream infection control measures in the country. These metrics highlight North America's strong institutional commitment to reducing healthcare-associated Bloodstream infections.

Bloodstream Infection Testing Market- Competitive Landscape:

Key companies operating in the Bloodstream Infection Testing market, such as T2 Biosystems, Inc., F. Hoffmann-La Roche Ltd, Siemens Healthcare Limited, Bruker, and Accelerate Diagnostics, Inc., are working towards increasing their market share through an expansion of their product portfolio and by updating their offering through launching new products, services, joint ventures, alliances, mergers and acquisitions, partnerships, and agreements. In September 2025, Roche bolstered its digital infection and sepsis management portfolio through strategic alliances with clinical laboratories for the incorporation of automated molecular diagnostics for early identification of pathogens in Bloodstreams into the workflow of hospitals. These strategic initiatives collectively drive market innovation and elevate clinical standards in Bloodstream infection testing.

Recent Developments:

In January 2026, Siemens Healthineers teamed up with hospital networks from the Asia-Pacific and Europe regions to automate processes employing the high-throughput automated blood culture system, which would be instrumental in aiding rapid detection and susceptibility testing for sepsis cases.

In March 2025, Accelerate Diagnostics filed the Accelerate WAVE system together with the Gramme Negative Positive Blood Culture test panel to the U.S. FDA in hopes of receiving 510(k) clearance for it. It will be beneficial in decreasing the turnaround times of rapid phenotypic susceptibility testing of Bloodstream infections.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BLOODSTREAM INFECTION TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• bioMerieux SA
• Becton, Dickinson and Company (BD)
• Cepheid
• Seegene Inc.
• T2 Biosystems, Inc.
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Luminex Corporation
• Bruker Corporation
• Accelerate Diagnostics, Inc.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Grifols S.A.
• Hologic, Inc.
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• DiaSorin S.p.A.
• Others

GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

• Reagents & Consumables
• Instruments

GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033

• Whole Blood
• Blood Culture

GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

• PCR
• In Situ Hybridization
• Mass Spectroscopy
• Others

GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

• Hospitals & Diagnostic Centers
• Academic & Research Institutes
• Custom Laboratory Service Providers
• Others

GLOBAL BLOODSTREAM INFECTION TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Bloodstream Infection Testing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
• 2.2. Competitive Insights

3. Bloodstream Infection Testing Key Market Trends

• 3.1. Bloodstream Infection Testing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Bloodstream Infection Testing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Bloodstream Infection Testing Market Opportunities
• 3.4. Bloodstream Infection Testing Market Future Trends

4. Bloodstream Infection Testing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Bloodstream Infection Testing Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Bloodstream Infection Testing Market Landscape

• 6.1. Bloodstream Infection Testing Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Bloodstream Infection Testing Market - By Product

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
  • 7.1.2. Reagents & Consumables
  • 7.1.3. Instruments

8. Bloodstream Infection Testing Market - By Sample Type

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
  • 8.1.2. Whole Blood
  • 8.1.3. Blood Culture

9. Bloodstream Infection Testing Market - By Technology

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
  • 9.1.2. PCR
  • 9.1.3. In Situ Hybridization
  • 9.1.4. Mass Spectroscopy
  • 9.1.5. Others

10. Bloodstream Infection Testing Market - By End User

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
  • 10.1.2. Hospitals & Diagnostic Centers
  • 10.1.3. Academic & Research Institutes
  • 10.1.4. Custom Laboratory Service Providers
  • 10.1.5. Others

11. Bloodstream Infection Testing Market - By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Bloodstream Infection Testing Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Bloodstream Infection Testing Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.17. Denmark
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Denmark Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.3.18. Rest of Europe
    • 11.3.18.1. Overview
    • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.3.18.5. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Bloodstream Infection Testing Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.16. Taiwan
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Taiwan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.17. Vietnam
    • 11.4.17.1. Overview
    • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.17.4. Vietnam Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.17.5. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.4.18. Rest of APAC
    • 11.4.18.1. Overview
    • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.4.18.4. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.4.18.5. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Bloodstream Infection Testing Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Bloodstream Infection Testing Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.14. Iran
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Iran Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.15. Qatar
    • 11.6.15.1. Overview
    • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.15.4. Qatar Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.15.5. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 11.6.16. Rest of MEA
    • 11.6.16.1. Overview
    • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 11.6.16.4. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
    • 11.6.16.5. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Bloodstream Infection Testing Industry

• 12.1. Competitive Benchmarking
  • 12.1.1. Competitive Dashboard
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. bioMerieux SA
  • 12.2.2. Becton, Dickinson and Company (BD)
  • 12.2.3. Cepheid
  • 12.2.4. Seegene Inc.
  • 12.2.5. T2 Biosystems, Inc.
  • 12.2.6. F. Hoffmann-La Roche Ltd
  • 12.2.7. Siemens Healthineers AG
  • 12.2.8. Luminex Corporation
  • 12.2.9. Bruker Corporation
  • 12.2.10. Accelerate Diagnostics, Inc.
  • 12.2.11. Thermo Fisher Scientific Inc.
  • 12.2.12. Abbott Laboratories
  • 12.2.13. Danaher Corporation
  • 12.2.14. Grifols S.A.
  • 12.2.15. Hologic, Inc.
  • 12.2.16. Bio-Rad Laboratories, Inc.
  • 12.2.17. QIAGEN N.V.
  • 12.2.18. DiaSorin S.p.A.
  • 12.2.19. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us